Cradle
Delft
About Cradle
Cradle is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins. Cradle offers complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data. Cradle offers a machine-learning platform that accelerates the development of new therapeutics and bio-based products like enzymes, antibodies, and chemicals. The platform is versatile, supporting various assets and use cases for both pharmaceutical and industrial applications, including enzymes, antibodies, peptides, vaccines, and therapeutic proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $102.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2024)
- Website: cradle.bio
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Product Research
Social Profiles
Canonical: https://fsome.com/organization/cradle-62558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.